Company profile
Pierre Fabre Pharmaceuticals (USA)
Our mission is to deliver new ways to care and breakthrough therapies in oncology and rare diseases.
- Industry
- Biotechnology Research
- Employees
- 83
- Headquarters
- Secaucus, New Jersey
- Founded
- 2024
- LinkedIn followers
- 5,016
- Office locations
- 1
Pierre Fabre Pharmaceuticals (USA) company summary
Pierre Fabre Pharmaceuticals (USA) is a company in the Biotechnology Research industry, headquartered in Secaucus, New Jersey, founded in 2024. On LinkedIn the company has around 83 employees and 5,016 followers.
What technology does Pierre Fabre Pharmaceuticals (USA) use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Pierre Fabre Pharmaceuticals (USA)
The mission of Pierre Fabre Pharmaceuticals (PFP) is to deliver breakthrough therapies in oncology and rare diseases to patient populations with high unmet needs and limited treatment options. Our belief is that every time we care for a single person, we make the whole world better. PFP is the US pharmaceutical subsidiary of Pierre Fabre Laboratories, a foundation-owned company with seven decades of impact. Pierre Fabre Laboratories is a global healthcare company, established in 43 countries, with 10,000 employees, and with products distributed in 120 territories across the globe. The Pierre Fabre Laboratories foundation ownership enhances the ability of the company to create long-term value for patients. Partnerships and acquisitions drive its innovative precision treatment pipeline and are enabled by the unique corporate structure. Building on the legacy of Pierre Fabre Laboratories, innovation is the life blood of PFP and patient experience drives everything the company does. PFP aspires to design and develop therapeutic solutions inspired by patients and healthcare professionals; draw on science and nature as perpetual sources of inspiration; develop long-term partnerships with researchers and innovators worldwide; and place pharmaceutical ethics and climate transition at the heart of our action. Pierre Fabre Pharmaceuticals has therapies in development for Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD), NRAS-mutant melanoma, non-small cell lung cancer with mutation or amplification of MET, and X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED). Pierre Fabre Pharmaceuticals is headquartered in Parsippany, NJ.
Where is Pierre Fabre Pharmaceuticals (USA) located?
Pierre Fabre Pharmaceuticals (USA) lists 1 location.
Compare companies similar to Pierre Fabre Pharmaceuticals (USA)
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Pierre Fabre Pharmaceuticals (USA) pierrefabrepharmaceuticals.com | Biotechnology Research | 83 | 2024 | Secaucus, New Jersey |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Pierre Fabre Pharmaceuticals (USA)
What does Pierre Fabre Pharmaceuticals (USA) do?
The mission of Pierre Fabre Pharmaceuticals (PFP) is to deliver breakthrough therapies in oncology and rare diseases to patient populations with high unmet needs and limited treatment options. Our belief is that every time we care for a single person, we make the whole world better. PFP is the US pharmaceutical subsidiary of Pierre Fabre Laboratories, a foundation-owned company with seven decades of impact. Pierre Fabre Laboratories is a global healthcare company, established in 43 countries, with 10,000 employees, and with products distributed in 120 territories across the globe. The Pierre Fabre Laboratories foundation ownership enhances the ability of the company to create long-term value for patients. Partnerships and acquisitions drive its innovative precision treatment pipeline and are enabled by the unique corporate structure. Building on the legacy of Pierre Fabre Laboratories, innovation is the life blood of PFP and patient experience drives everything the company does. PFP aspires to design and develop therapeutic solutions inspired by patients and healthcare professionals; draw on science and nature as perpetual sources of inspiration; develop long-term partnerships with researchers and innovators worldwide; and place pharmaceutical ethics and climate transition at the heart of our action. Pierre Fabre Pharmaceuticals has therapies in development for Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD), NRAS-mutant melanoma, non-small cell lung cancer with mutation or amplification of MET, and X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED). Pierre Fabre Pharmaceuticals is headquartered in Parsippany, NJ.
How many employees does Pierre Fabre Pharmaceuticals (USA) have?
Pierre Fabre Pharmaceuticals (USA) has around 83 employees on LinkedIn.
Where is Pierre Fabre Pharmaceuticals (USA) headquartered?
Pierre Fabre Pharmaceuticals (USA) is headquartered in Secaucus, New Jersey.
When was Pierre Fabre Pharmaceuticals (USA) founded?
Pierre Fabre Pharmaceuticals (USA) was founded in 2024.
Build a lead list from companies like Pierre Fabre Pharmaceuticals (USA)
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.